5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.45▲ | 2.44▲ | 2.46▼ | 2.62▼ | 2.88▼ |
MA10 | 2.46▼ | 2.50▼ | 2.57▼ | 2.74▼ | 2.98▼ |
MA20 | 2.55▼ | 2.60▼ | 2.62▼ | 2.88▼ | 3.09▼ |
MA50 | 2.64▼ | 2.71▼ | 2.77▼ | 2.98▼ | 2.67▼ |
MA100 | 2.74▼ | 2.83▼ | 2.89▼ | 3.13▼ | 1.84▲ |
MA200 | 2.88▼ | 3.02▼ | 3.05▼ | 2.80▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | -0.016▼ | -0.020▼ | -0.039▼ | -0.101▼ |
RSI | 33.925▼ | 32.701▼ | 33.781▼ | 32.404▼ | 39.604▼ |
STOCH | 30.688 | 8.541▼ | 5.964▼ | 15.764▼ | 49.436 |
WILL %R | -77.500▼ | -86.765▼ | -86.765▼ | -94.184▼ | -81.169▼ |
CCI | -46.586 | -65.146 | -87.246 | -170.102▼ | -189.506▼ |
Tuesday, June 10, 2025 04:24 AM
The company plans to initiate a Phase 1 study of MRT-8102 in the coming weeks and ... the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...
|
Monday, June 09, 2025 09:00 PM
MRT-8102, a highly selective NEK7-directed molecular ... Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based ...
|
Friday, June 06, 2025 05:36 AM
Marti sets new targets for September 30, 2025 of 2.50 million riders and 350 thousand registered drivers Marti Technologies, Inc. ("Marti" or the "Company") (NYSE American: MRT), Türkiye's ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 2.68 | 2.68 | 2.41 | 2.45 | 174,619 |
12/06/25 | 2.75 | 2.7968 | 2.69 | 2.72 | 25,923 |
11/06/25 | 2.65 | 2.7767 | 2.6301 | 2.73 | 113,849 |
10/06/25 | 2.665 | 2.68 | 2.615 | 2.615 | 50,810 |
09/06/25 | 2.85 | 2.90 | 2.60 | 2.60 | 255,130 |
06/06/25 | 2.87 | 2.9237 | 2.80 | 2.81 | 53,718 |
05/06/25 | 2.91 | 2.91 | 2.74 | 2.80 | 62,336 |
04/06/25 | 2.85 | 2.9384 | 2.8313 | 2.885 | 26,066 |
03/06/25 | 2.94 | 2.9409 | 2.85 | 2.86 | 51,802 |
02/06/25 | 2.98 | 2.98 | 2.92 | 2.9416 | 26,513 |
|
|
||||
|
|
||||
|
|